Quantum biopharma licensee unbuzzd wellness inc. commences reg d capital raise campaign to fund growth and possible ipo

Toronto, july 31, 2025 (globe newswire) -- quantum biopharma ltd. (nasdaq: qntm) (cse: qntm) (fra: 0k91) (“quantum biopharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announced that unbuzzd wellness inc. (the "company" or "unbuzzd"), the company behind unbuzzdtm – the scientifically-proven and game-changing beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms – today announced the launch of its previously announced regulation d 506(c) offering to raise up to us$5.0 million to fund growth and establish a path to a possible initial public offering.
QNTM Ratings Summary
QNTM Quant Ranking